Literature DB >> 32814891

The antibiotic paradox: why companies can't afford to create life-saving drugs.

Maryn McKenna.   

Abstract

Keywords:  Antibiotics; Business; Diseases; Infection

Mesh：

Substances：

Year:  2020        PMID： 32814891     DOI： 10.1038/d41586-020-02418-x

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides.

Authors:  Napoleon D'Cunha; Mohammad Moniruzzaman; Keith Haynes; Giuliano Malloci; Connor J Cooper; Enrico Margiotta; Attilio V Vargiu; Muhammad R Uddin; Inga V Leus; Feng Cao; Jerry M Parks; Valentin V Rybenkov; Paolo Ruggerone; Helen I Zgurskaya; John K Walker
Journal:  ACS Infect Dis       Date:  2021-08-11       Impact factor: 5.578

2.  A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development.

Authors:  Lucas Böttcher; Hans Gersbach
Journal:  Bull Math Biol       Date:  2022-04-22       Impact factor: 3.871

3.  A shared future: chemistry's engagement is essential for resilience of people and planet.

Authors:  Goverdhan Mehta; Sarah E Cornell; Alain Krief; Henning Hopf; Stephen A Matlin
Journal:  R Soc Open Sci       Date:  2022-04-20       Impact factor: 3.653

Review 4.  Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Mohammed Alqarni; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

5.  Comparing optimization criteria in antibiotic allocation protocols.

Authors:  Alastair Jamieson-Lane; Alexander Friedrich; Bernd Blasius
Journal:  R Soc Open Sci       Date:  2022-03-23       Impact factor: 2.963

6.  Photodegradable antimicrobial agents - synthesis, photodegradation, and biological evaluation.

Authors:  Vebjørn Eikemo; Leiv K Sydnes; Magne O Sydnes
Journal:  RSC Adv       Date:  2021-09-30       Impact factor: 4.036

Review 7.  Incorporation of Antibiotics into Solid Lipid Nanoparticles: A Promising Approach to Reduce Antibiotic Resistance Emergence.

Authors:  Lide Arana; Lucia Gallego; Itziar Alkorta
Journal:  Nanomaterials (Basel)       Date:  2021-05-10       Impact factor: 5.076

Review 8.  The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia.

Authors:  Jaclyn G McCutcheon; Jonathan J Dennis
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

9.  CryoEM structure of the outer membrane secretin channel pIV from the f1 filamentous bacteriophage.

Authors:  Rebecca Conners; Mathew McLaren; Urszula Łapińska; Kelly Sanders; M Rhia L Stone; Mark A T Blaskovich; Stefano Pagliara; Bertram Daum; Jasna Rakonjac; Vicki A M Gold
Journal:  Nat Commun       Date:  2021-11-02       Impact factor: 14.919

10.  There is no market for new antibiotics: this allows an open approach to research and development.

Authors:  Dana M Klug; Fahima I M Idiris; Mark A T Blaskovich; Frank von Delft; Christopher G Dowson; Claas Kirchhelle; Adam P Roberts; Andrew C Singer; Matthew H Todd
Journal:  Wellcome Open Res       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.